Matthew A Duncton

Title: Matthew A Duncton: Innovator in Pharmaceutical Development

Introduction

Matthew A Duncton is a notable inventor in the field of pharmaceuticals, particularly recognized for his work on derivatives of relebactam. He is based in the United States and has made significant contributions to the treatment of bacterial infections through innovative therapeutic methods.

Latest Patents

Matthew A Duncton holds a patent titled "Derivatives Of Relebactam And Uses Thereof." This patent focuses on derivatives of relebactam selected from specific compounds and their pharmaceutically acceptable salts. The therapeutic methods outlined in the patent emphasize the use of these derivatives in combination with beta-lactam antibiotics, particularly for treating bacterial infections. The derivatives are designed to be suitable for oral administration.

Career Highlights

Duncton is currently associated with Arixa Pharmaceuticals, Inc., where he continues to advance his research and development efforts in the pharmaceutical sector. His work is pivotal in creating effective treatments that address pressing health concerns.

Collaborations

Some of his notable coworkers include Eric M Gordon and John Freund, who contribute to the collaborative efforts at Arixa Pharmaceuticals, Inc. Their combined expertise enhances the innovative environment within the company.

Conclusion

Matthew A Duncton is a significant figure in pharmaceutical innovation, particularly in developing treatments for bacterial infections. His contributions through patents and collaboration with esteemed colleagues underscore his commitment to advancing healthcare solutions.